Bill Text: NY S02087 | 2019-2020 | General Assembly | Introduced
Bill Title: Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy in trust for the health plan or provider and provides for accountability of such funds; further provides for an appeals process to investigate and resolve disputes regarding multi-source generic drug pricing.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced - Dead) 2020-01-08 - REFERRED TO HEALTH [S02087 Detail]
Download: New_York-2019-S02087-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 2087 2019-2020 Regular Sessions IN SENATE January 22, 2019 ___________ Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to pharmacy benefit managers; and to repeal certain provisions of such law relating there- to The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Section 280-a of the public health law is REPEALED and a 2 new section 280-a is added to read as follows: 3 § 280-a. Pharmacy benefit managers. 1. Definitions. As used in this 4 section, the following terms shall have the following meanings: 5 (a) "Health plan or provider" means an entity for which a pharmacy 6 benefit manager provides pharmacy benefit management including, but not 7 limited to: (i) a health benefit plan or other entity that approves, 8 provides, arranges for, or pays for health care items or services, under 9 which prescription drugs for beneficiaries of the entity are purchased 10 or which provides or arranges reimbursement in whole or in part for the 11 purchase of prescription drugs; or (ii) a health care provider or 12 professional, including a state or local government entity, that 13 acquires prescription drugs to use or dispense in providing health care 14 to patients. 15 (b) "Pharmacy benefit management" means the service provided to a 16 health plan or provider, directly or through another entity, and regard- 17 less of whether the pharmacy benefit manager and the health plan or 18 provider are related, or associated by ownership, common ownership, 19 organization or otherwise; including the procurement of prescription 20 drugs to be dispensed to patients, or the administration or management 21 of prescription drug benefits, including but not limited to, any of the 22 following: 23 (i) mail service pharmacy; EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD06526-02-9S. 2087 2 1 (ii) claims processing, retail network management, or payment of 2 claims to pharmacies for dispensing prescription drugs; 3 (iii) clinical or other formulary or preferred drug list development 4 or management; 5 (iv) negotiation or administration of rebates, discounts, payment 6 differentials, or other incentives, for the inclusion of particular 7 prescription drugs in a particular category or to promote the purchase 8 of particular prescription drugs; 9 (v) patient compliance, therapeutic intervention, or generic substi- 10 tution programs; and 11 (vi) disease management. 12 (c) "Pharmacy benefit manager" means any entity that performs pharmacy 13 benefit management for a health plan or provider. 14 (d) "Maximum allowable cost price" means a maximum reimbursement 15 amount set by the pharmacy benefit manager for therapeutically equiv- 16 alent multiple source generic drugs. 17 (e) "Controlling person" means any person or other entity who or which 18 directly or indirectly has the power to direct or cause to be directed 19 the management, control or activities of a pharmacy benefit manager. 20 (f) "Covered individual" means a member, participant, enrollee, 21 contract holder or policy holder or beneficiary of a health plan or 22 provider. 23 (g) "License" means a license to be a pharmacy benefit manager, under 24 subdivision seven of this section. 25 (h) "Spread pricing" means the practice of a pharmacy benefit manager 26 retaining an additional amount of money in addition to the amount paid 27 to the pharmacy to fill a prescription. 28 2. Duty, accountability and transparency. (a) The pharmacy benefit 29 manager shall have a fiduciary relationship with and obligation to the 30 health plan or provider, and shall perform pharmacy benefit management 31 with care, skill, prudence, diligence, and professionalism. 32 (b) All funds received by the pharmacy benefit manager in relation to 33 providing pharmacy benefit management shall be received by the pharmacy 34 benefit manager in trust for the health plan or provider and shall be 35 used or distributed only pursuant to the pharmacy benefit manager's 36 contract, or other terms in the absence of a contract, with the health 37 plan or provider or applicable law; except for any administrative fee or 38 payment expressly provided for in the contract, or other terms in the 39 absence of a contract, between the pharmacy benefit manager and the 40 health plan or provider to compensate the pharmacy benefit manager for 41 its services. Any funds received by the pharmacy benefit manager 42 through spread pricing shall be subject to this paragraph. 43 (c) The pharmacy benefit manager shall periodically account to the 44 health plan or provider for all funds received by the pharmacy benefit 45 manager. The health plan or provider shall have access to all financial 46 and utilization information of the pharmacy benefit manager in relation 47 to pharmacy benefit management provided to the health plan or provider. 48 (d) The pharmacy benefit manager shall disclose in writing to the 49 health plan or provider the terms and conditions of any contract or 50 arrangement between the pharmacy benefit manager and any party relating 51 to pharmacy benefit management provided to the health plan or provider. 52 (e) The pharmacy benefit manager shall disclose in writing to the 53 health plan or provider any activity, policy, practice, contract or 54 arrangement of the pharmacy benefit manager that directly or indirectly 55 presents any conflict of interest with the pharmacy benefit manager's 56 relationship with or obligation to the health plan or provider.S. 2087 3 1 (f) Any information required to be disclosed by a pharmacy benefit 2 manager to a health plan or provider under this section that is reason- 3 ably designated by the pharmacy benefit manager as proprietary or trade 4 secret information shall be kept confidential by the health plan or 5 provider, except as required or permitted by law, including disclosure 6 necessary to prosecute or defend any legitimate legal claim or cause of 7 action. 8 (g) The commissioner shall establish, by regulation, minimum standards 9 for pharmacy benefit management services which shall address the elimi- 10 nation of conflicts of interest between pharmacy benefit managers and 11 health insurers, plans and providers; and the elimination of deceptive 12 practices, anti-competitive practices, and unfair claims practices. 13 3. Prescriptions. A pharmacy benefit manager may not substitute or 14 cause the substituting of one prescription drug for another in dispens- 15 ing a prescription, or alter or cause the altering of the terms of a 16 prescription, except with the approval of the prescriber or as explicit- 17 ly required or permitted by law. 18 4. Appeals. A pharmacy benefit manager shall, with respect to 19 contracts between a pharmacy benefit manager and a pharmacy or, alterna- 20 tively, a pharmacy benefit manager and a pharmacy's contracting agent, 21 such as a pharmacy services administrative organization, include a 22 reasonable process to appeal, investigate and resolve disputes regarding 23 multi-source generic drug pricing. The appeals process shall include the 24 following provisions: 25 (a) the right to appeal by the pharmacy and/or the pharmacy's 26 contracting agent shall be limited to thirty days following the initial 27 claim submitted for payment; 28 (b) a telephone number through which a network pharmacy may contact 29 the pharmacy benefit manager for the purpose of filing an appeal and an 30 electronic mail address of the individual who is responsible for proc- 31 essing appeals; 32 (c) the pharmacy benefit manager shall send an electronic mail message 33 acknowledging receipt of the appeal. The pharmacy benefit manager shall 34 respond in an electronic message to the pharmacy and/or the pharmacy's 35 contracting agent filing the appeal within seven business days indicat- 36 ing its determination. If the appeal is determined to be valid, the 37 maximum allowable cost for the drug shall be adjusted for the appealing 38 pharmacy effective as of the date of the original claim for payment. The 39 pharmacy benefit manager shall require the appealing pharmacy to reverse 40 and rebill the claim in question in order to obtain the corrected 41 reimbursement; 42 (d) if an update to the maximum allowable cost is warranted, the phar- 43 macy benefit manager or covered entity shall adjust the maximum allow- 44 able cost of the drug effective for all similarly situated pharmacies in 45 its network in the state on the date the appeal was determined to be 46 valid; and 47 (e) if an appeal is denied, the pharmacy benefit manager shall identi- 48 fy the national drug code of a therapeutically equivalent drug, as 49 determined by the federal Food and Drug Administration, that is avail- 50 able for purchase by pharmacies in this state from wholesalers regis- 51 tered pursuant to subdivision four of section sixty-eight hundred eight 52 of the education law at a price which is equal to or less than the maxi- 53 mum allowable cost for that drug as determined by the pharmacy benefit 54 manager. 55 5. Contract provisions. No pharmacy benefit manager shall, with 56 respect to contracts between such pharmacy benefit manager and a pharma-S. 2087 4 1 cy or, alternatively, such pharmacy benefit manager and a pharmacy's 2 contracting agent, such as a pharmacy services administrative organiza- 3 tion: 4 (a) prohibit or penalize a pharmacist or pharmacy from disclosing to 5 an individual purchasing a prescription medication information regard- 6 ing: 7 (1) the cost of the prescription medication to the individual, or 8 (2) the availability of any therapeutically equivalent alternative 9 medications or alternative methods of purchasing the prescription medi- 10 cation, including but not limited to, paying a cash price; 11 (b) charge or collect from an individual a copayment that exceeds the 12 total submitted charges by the pharmacy for which the pharmacy is paid. 13 If an individual pays a copayment, the pharmacy shall retain the adjudi- 14 cated costs and the pharmacy benefit manager shall not redact or recoup 15 the adjudicated cost; or 16 (c) require a pharmacy to meet any pharmacy accreditation standard or 17 recertification requirement inconsistent with, more stringent than, or 18 in addition to federal and state requirements for licensure as a pharma- 19 cy. 20 6. Acting without a license. (a) No person or entity may act as a 21 pharmacy benefit manager on or after January first, two thousand twen- 22 ty-one without having a currently valid license under this section. 23 However, a pharmacy benefit manager providing pharmacy benefit manage- 24 ment on and before that date may continue to do so without a license 25 under this section for a period of one hundred eighty days. 26 (b) No health plan or provider may pay any fee or other compensation 27 for pharmacy benefit management to any person or entity acting in 28 violation of this subdivision. 29 (c) Any person or entity that violates this section shall be subject 30 to penalties under sections twelve and twelve-b of this chapter. 31 7. Licensing of pharmacy benefit managers. (a) The commissioner may 32 issue a pharmacy benefit manager license to any person or entity who or 33 that applies for a license and has complied with the requirements of 34 this section. The commissioner may establish, by regulation, minimum 35 standards for the issuance of a license to a pharmacy benefit manager. 36 The term of each license shall be a period of five years and may be 37 renewed by the commissioner. 38 (b)(1) Before a pharmacy benefit manager's license shall be issued or 39 renewed, the prospective licensee shall file a written application in 40 such form or forms and supplements as the commissioner may require, and 41 pay a fee of ten thousand dollars. 42 (2) Every license issued pursuant to this section may be renewed by 43 filing the application and paying the fees at least sixty days prior to 44 the expiration of the license, upon which the license shall continue in 45 full force and effect until either (A) the issuance by the commissioner 46 of the renewed license or (B) five business days after the commissioner 47 shall have given notice to the applicant that the commissioner has 48 rejected the renewal. 49 (c) The commissioner may refuse to issue or renew a pharmacy benefit 50 manager's license if, in the commissioner's judgment, the applicant or 51 any member, principal, officer or director of the applicant, is not 52 trustworthy or competent to act as a pharmacy benefit manager, or if the 53 commissioner is aware of cause for revocation or suspension of such 54 license. The commissioner shall notify the licensee of a determination 55 to reject the application for the license or renewal and an explanationS. 2087 5 1 of the cause for rejection, and shall provide a reasonable opportunity 2 for the licensee to be heard under subdivision eight of this section. 3 (d) Licensees shall be subject to examination at any time by the 4 commissioner. 5 8. Revocation or suspension of a license. (a) The commissioner, upon 6 his or her own investigation or complaint from another party, may 7 revoke, suspend or refuse to renew a license if, after notice and hear- 8 ing, the commissioner determines that the licensee, has, in relation to 9 pharmacy benefit management or the operation of the pharmacy benefit 10 manager: 11 (1) violated any law, regulation, subpoena or order of the commission- 12 er, or of another state that would constitute a violation in New York; 13 (2) provided materially incorrect, materially misleading, materially 14 incomplete or materially untrue information in a license application; 15 (3) obtained or attempted to obtain a license through misrepresen- 16 tation or fraud; 17 (4) used fraudulent, coercive or dishonest practices; 18 (5) demonstrated incompetence; 19 (6) demonstrated untrustworthiness; 20 (7) demonstrated financial irresponsibility in the conduct of the 21 business; 22 (8) improperly withheld, misappropriated or converted any monies or 23 properties; 24 (9) intentionally misrepresented the terms of an actual or proposed 25 contract with any party; 26 (10) been convicted of a felony; 27 (11) had a pharmacy benefit manager license, or its equivalent, 28 denied, suspended or revoked in any other state, province, district or 29 territory; or 30 (12) ceased to meet the requirements for licensure under this section. 31 (b) Before revoking, suspending or refusing to renew a license, the 32 commissioner shall give notice to the licensee and shall hold, or cause 33 to be held, a hearing as provided under section twelve-a of this chap- 34 ter. The commissioner shall also give notice to health plans and provid- 35 ers under contract with the pharmacy benefit manager, to the extent 36 known to the commissioner. 37 (c) If a license is revoked or suspended, the commissioner shall give 38 notice to the licensee and health plans and providers under contract 39 with the pharmacy benefit manager to the extent known to the commission- 40 er. 41 9. Change of address. A registrant or licensee under this section 42 shall inform the commissioner by a means acceptable to the commissioner 43 of a change of address within thirty days of the change. 44 10. Violations. Any provision of a contract that violates the 45 provisions of this section shall be deemed to be void and unenforceable. 46 11. Beginning June first, two thousand twenty, and annually thereaft- 47 er, each pharmacy benefit manager shall submit to the department a tran- 48 sparency report containing data for the prior calendar year. The trans- 49 parency report shall contain the following information as to the 50 pharmacy benefit manager: 51 (i) the aggregate amount of all rebates received from all pharmaceu- 52 tical manufacturers for all health plans or providers; 53 (ii) the aggregate administrative fees received from all pharmaceu- 54 tical manufacturers for all health plans or providers under contract 55 with the pharmacy benefit manager;S. 2087 6 1 (iii) the aggregate amounts retained as compensation received from all 2 pharmaceutical manufacturers for health plans or providers not under 3 contract with the pharmacy benefit manager as provided under this 4 section; and 5 (iv) the aggregate amounts, and such amounts as a percentage of 6 rebates received from pharmaceutical manufacturers, retained under 7 spread pricing for each health plan or provider. 8 § 2. Severability. If any provision of this act, or any application 9 of any provision of this act, is held to be invalid, or ruled by any 10 federal agency to violate or be inconsistent with any applicable federal 11 law or regulation, that shall not affect the validity or effectiveness 12 of any other provision of this act, or of any other application of any 13 provision of this act. 14 § 3. This act shall take effect on the ninetieth day after it shall 15 become a law and shall apply to any contract for providing pharmacy 16 benefit management made or renewed on or after that date. Effective 17 immediately, the commissioner of health shall make regulations and take 18 other actions reasonably necessary to implement this act on that date.